// App-Quantinova.ai

11093 : Altered Natural Killer Cell Subsets, Phenotype and Activity in Adamts13-deficient TTP Patients With a History of Relapse

Researchers

Presenter

  • Christina Lawrence

Principal Investigators

  • Contessa Edgar

  • Zijian Pan

  • Christopher Horton

  • Eric Dumas

  • Deirdra Terrell

  • Sara Vesely

  • James George

  • A. Darise Farris

Medical Centers

  • Oklahoma Medical Res Fndn, Oklahoma City, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombotic thrombocytopenic purpura

  • Thrombotic microangiopathy

  • Venous thrombosis

Biomarkers

  • Natural Killer cells

  • Peripheral blood mononuclear cell

  • Cluster of differentiation 69

  • Fc gamma RIIIa

  • Human Leukocyte Antigen – DR isotype

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • lonomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved